Labcorp Holdings recently reported better-than-expected Q3 2025 adjusted EPS of $4.18 but cut its contract research unit’s annual and full-year revenue growth forecasts due to a prolonged funding ...

A St. Louis biotech company has secured new funding from a major lab services business and a health system venture capital ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

St. Louis-based Ascension Ventures and Labcorp have invested in a strategic financing round for Cofactor Genomics. The company’s flagship test, OncoPrism, uses machine learning to analyze tumors and ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...

Labcorp's strategic partnerships, specialty test growth and more attractive valuation tilt the balance as it emerges stronger than Hologic right now.

Onconetix ( (ONCO)) has shared an announcement. On December 6, 2025, Proteomedix AG, a subsidiary of Onconetix, Inc., amended its license agreement with Labcorp to conduct a new validation study for ...